ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Byooviz 10 mg / mL, Injektionslösung in Durchstechflasche - 
68690002 Samsung Bioepis CH GmbH
Byooviz 10 mg / mL, Injektionslösung in Durchstechflasche13.07.2022
  13.07.2022
Ranibizumab (S01LA04) 
WHO-DDD12.07.2027
11.99. 
11.99. 
B  
No 
IP 
PR  
k.A.PR
  
7680686900028Biotechnologika
  
Composition
ranibizumabum 10 mg, trehalosum dihydricum, histidini hydrochloridum monohydricum, histidinum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Packungsbestandteile
Injection solution 
  
 
Active AgentDose
Ranibizumab10 mg/ml
BAG: Active AgentDose
Ranibizumab2.3 mg
 
Inactive agents
Histidin Hydrochloride Monohydrate
Histidine
Polysorbatum 20
Trehalosum Dihydricum
 
Source
Data was imported : 08.06.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home